T. Rowe Price Investment Management »

Fate Therapeutics shares owned by T. Rowe Price Investment Management

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by T. Rowe Price Investment Management from 13F filings

Historical chart of T. Rowe Price Investment Management investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by T. Rowe Price Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by T. Rowe Price Investment Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $500k 105k 4.76
2023-03-31 $571k 100k 5.71
2022-12-31 $4.4M 434k 10.09

More positions owned by T. Rowe Price Investment Management

Microsoft Corp Comm Stk (MSFT)
Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Amazon Comm Stk (AMZN)
PTC Comm Stk (PTC)
Becton Dickinson & Co Comm Stk (BDX)
Meta Platforms Comm Stk (META)
Yum Brands Comm Stk (YUM)
Abbott Labs Comm Stk (ABT)
Alphabet Comm Stk (GOOGL)
Centerpoint Energy Comm Stk (CNP)
Revvity Comm Stk (RVTY)
Nisource Comm Stk (NI)
Advanced Micro Devices Comm Stk (AMD)
Ameren Corp Comm Stk (AEE)

View all positions for T. Rowe Price Investment Management

Top funds holding Fate Therapeutics

Redmile Group
BlackRock
Vanguard Group
Wilshire Associates
Johnson & Johnson
Acadian Asset Management
Geode Capital Management
Vestal Point Capital
State Street Corporation
Dimensional Fund Advisors
Tang Capital Management
Goldman Sachs Group
Renaissance Technologies
AQR Capital Management
Two Sigma Advisers

View all funds holding Fate Therapeutics